PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 106 filers reported holding PMV PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.78 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,539,852 | -1.6% | 2,042,321 | +0.4% | 0.00% | – |
| Q2 2023 | $12,739,306 | +36.0% | 2,035,033 | +3.6% | 0.00% | – |
| Q1 2023 | $9,365,513 | -60.9% | 1,963,420 | -28.7% | 0.00% | -100.0% |
| Q4 2022 | $23,956,373 | -41.4% | 2,753,606 | -19.8% | 0.00% | 0.0% |
| Q3 2022 | $40,865,000 | -14.5% | 3,433,965 | +2.3% | 0.00% | 0.0% |
| Q2 2022 | $47,823,000 | -16.1% | 3,355,964 | +22.5% | 0.00% | 0.0% |
| Q1 2022 | $57,023,000 | -6.8% | 2,738,883 | +3.4% | 0.00% | 0.0% |
| Q4 2021 | $61,167,000 | -22.6% | 2,647,946 | -0.2% | 0.00% | -50.0% |
| Q3 2021 | $79,071,000 | +3.3% | 2,653,394 | +18.4% | 0.00% | 0.0% |
| Q2 2021 | $76,576,000 | +96.1% | 2,241,711 | +88.8% | 0.00% | +100.0% |
| Q1 2021 | $39,050,000 | -45.2% | 1,187,278 | +2.5% | 0.00% | -50.0% |
| Q4 2020 | $71,260,000 | +9936.6% | 1,158,507 | +5692.5% | 0.00% | – |
| Q3 2020 | $710,000 | – | 20,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERWEST VENTURE MANAGEMENT CO | 1,614,911 | $9,915,554 | 48.05% |
| OUP Management Co., LLC | 989,232 | $6,073,884 | 13.66% |
| Euclidean Capital LLC | 5,255,286 | $32,267,456 | 3.52% |
| Tri Locum Partners LP | 821,384 | $5,043,298 | 1.61% |
| Ghost Tree Capital, LLC | 705,881 | $4,334,109 | 1.42% |
| Boxer Capital, LLC | 3,163,795 | $19,425,701 | 1.03% |
| Mesirow Financial Investment Management, Inc. | 34,748 | $213,353 | 0.93% |
| Orbimed Advisors | 6,563,077 | $40,297,293 | 0.86% |
| Octagon Capital Advisors LP | 904,000 | $5,550,560 | 0.85% |
| Nextech Invest Ltd. | 421,284 | $2,586,684 | 0.78% |